Impact of transport and drug properties on the local pharmacology of drug-eluting stents

Chao-Wei Hwang, David Wu, Elazer R. Edelman

Research output: Contribution to journalArticle

Abstract

Drugs released from stents are driven by physiological transport forces, principally solvent-driven flow (convection) and random molecular agitation (diffusion). The relative strength of these two forces determines drug penetration and distribution in the arterial wall. Drug physicochemical factors can induce critical modulations to the primary distribution, both transiently and at steady state. Hydrophobic interactions and non-specific binding, for example, can both result in tissue drug concentrations severalfold above administered concentration. Drug interaction with native proteins may also interfere with drug transfer at the stent-artery interface. These transport forces and tissue interactions can induce local drug concentrations even at steady state to vary by one or more orders of magnitude over the span of a few cells. To account for significant local variations in drug concentrations following stent-based delivery, rational design of vascular delivery systems requires consideration of drug distribution and tissue interactions on a local, continuum basis. Continuum analysis adapts traditional pharmacokinetics to the local environment by supplementing discrete global parameters of drug content with continuous local values of concentration, transport and binding. The interplay of these parameters with local flux conditions and drug and tissue properties defines the local drug distribution in space and over time. This type of analysis may well become increasingly relevant given the trend toward stent-based drug therapy in cardiovascular care.

Original languageEnglish (US)
Pages (from-to)7-12
Number of pages6
JournalInternational Journal of Cardiovascular Interventions
Volume5
Issue number1
DOIs
StatePublished - 2003
Externally publishedYes

Fingerprint

Drug-Eluting Stents
Pharmacology
Pharmaceutical Preparations
Stents
Convection
Tissue Distribution
Hydrophobic and Hydrophilic Interactions
Drug Interactions
Blood Vessels
Pharmacokinetics
Arteries

Keywords

  • Continuum analysis
  • Drug-eluting
  • Stent

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Impact of transport and drug properties on the local pharmacology of drug-eluting stents. / Hwang, Chao-Wei; Wu, David; Edelman, Elazer R.

In: International Journal of Cardiovascular Interventions, Vol. 5, No. 1, 2003, p. 7-12.

Research output: Contribution to journalArticle

@article{f9a1bb6a1754465cbf0d90dbe9f59928,
title = "Impact of transport and drug properties on the local pharmacology of drug-eluting stents",
abstract = "Drugs released from stents are driven by physiological transport forces, principally solvent-driven flow (convection) and random molecular agitation (diffusion). The relative strength of these two forces determines drug penetration and distribution in the arterial wall. Drug physicochemical factors can induce critical modulations to the primary distribution, both transiently and at steady state. Hydrophobic interactions and non-specific binding, for example, can both result in tissue drug concentrations severalfold above administered concentration. Drug interaction with native proteins may also interfere with drug transfer at the stent-artery interface. These transport forces and tissue interactions can induce local drug concentrations even at steady state to vary by one or more orders of magnitude over the span of a few cells. To account for significant local variations in drug concentrations following stent-based delivery, rational design of vascular delivery systems requires consideration of drug distribution and tissue interactions on a local, continuum basis. Continuum analysis adapts traditional pharmacokinetics to the local environment by supplementing discrete global parameters of drug content with continuous local values of concentration, transport and binding. The interplay of these parameters with local flux conditions and drug and tissue properties defines the local drug distribution in space and over time. This type of analysis may well become increasingly relevant given the trend toward stent-based drug therapy in cardiovascular care.",
keywords = "Continuum analysis, Drug-eluting, Stent",
author = "Chao-Wei Hwang and David Wu and Edelman, {Elazer R.}",
year = "2003",
doi = "10.1080/14628840304614",
language = "English (US)",
volume = "5",
pages = "7--12",
journal = "Acute Cardiac Care",
issn = "1748-2941",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Impact of transport and drug properties on the local pharmacology of drug-eluting stents

AU - Hwang, Chao-Wei

AU - Wu, David

AU - Edelman, Elazer R.

PY - 2003

Y1 - 2003

N2 - Drugs released from stents are driven by physiological transport forces, principally solvent-driven flow (convection) and random molecular agitation (diffusion). The relative strength of these two forces determines drug penetration and distribution in the arterial wall. Drug physicochemical factors can induce critical modulations to the primary distribution, both transiently and at steady state. Hydrophobic interactions and non-specific binding, for example, can both result in tissue drug concentrations severalfold above administered concentration. Drug interaction with native proteins may also interfere with drug transfer at the stent-artery interface. These transport forces and tissue interactions can induce local drug concentrations even at steady state to vary by one or more orders of magnitude over the span of a few cells. To account for significant local variations in drug concentrations following stent-based delivery, rational design of vascular delivery systems requires consideration of drug distribution and tissue interactions on a local, continuum basis. Continuum analysis adapts traditional pharmacokinetics to the local environment by supplementing discrete global parameters of drug content with continuous local values of concentration, transport and binding. The interplay of these parameters with local flux conditions and drug and tissue properties defines the local drug distribution in space and over time. This type of analysis may well become increasingly relevant given the trend toward stent-based drug therapy in cardiovascular care.

AB - Drugs released from stents are driven by physiological transport forces, principally solvent-driven flow (convection) and random molecular agitation (diffusion). The relative strength of these two forces determines drug penetration and distribution in the arterial wall. Drug physicochemical factors can induce critical modulations to the primary distribution, both transiently and at steady state. Hydrophobic interactions and non-specific binding, for example, can both result in tissue drug concentrations severalfold above administered concentration. Drug interaction with native proteins may also interfere with drug transfer at the stent-artery interface. These transport forces and tissue interactions can induce local drug concentrations even at steady state to vary by one or more orders of magnitude over the span of a few cells. To account for significant local variations in drug concentrations following stent-based delivery, rational design of vascular delivery systems requires consideration of drug distribution and tissue interactions on a local, continuum basis. Continuum analysis adapts traditional pharmacokinetics to the local environment by supplementing discrete global parameters of drug content with continuous local values of concentration, transport and binding. The interplay of these parameters with local flux conditions and drug and tissue properties defines the local drug distribution in space and over time. This type of analysis may well become increasingly relevant given the trend toward stent-based drug therapy in cardiovascular care.

KW - Continuum analysis

KW - Drug-eluting

KW - Stent

UR - http://www.scopus.com/inward/record.url?scp=0037281019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037281019&partnerID=8YFLogxK

U2 - 10.1080/14628840304614

DO - 10.1080/14628840304614

M3 - Article

C2 - 12623559

AN - SCOPUS:0037281019

VL - 5

SP - 7

EP - 12

JO - Acute Cardiac Care

JF - Acute Cardiac Care

SN - 1748-2941

IS - 1

ER -